These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 3199518
1. [Mechanism of action and molecular design of hypoxic cell sensitizer]. Nishimoto S, Kagiya T. Gan No Rinsho; 1988 Oct; 34(13):1853-8. PubMed ID: 3199518 [Abstract] [Full Text] [Related]
2. Importance of tumor affinity of nitroazoles in hypoxic radiosensitization. Kagiya T, Nishimoto S, Shibamoto Y, Wang J, Zhou L, He YL, Sasai K, Takahashi M, Abe M. Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1033-7. PubMed ID: 2703382 [Abstract] [Full Text] [Related]
3. [Developments in the experimental methods of evaluating hypoxic cell sensitizers]. Shibamoto Y, Sasai K, Takahashi M, Abe M. Gan No Rinsho; 1988 Oct; 34(13):1859-63. PubMed ID: 3199519 [Abstract] [Full Text] [Related]
4. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization. Kagiya VT, Nishimoto S, Ito T, Wang J, Abe M, Sasai K. Int J Radiat Oncol Biol Phys; 1992 Oct; 22(3):601-5. PubMed ID: 1735699 [Abstract] [Full Text] [Related]
5. [Radiosensitizer: hypoxic cell radiosensitizer]. Mori T. Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001 [Abstract] [Full Text] [Related]
10. Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization. Jette DC, Wiebe LI, Flanagan RJ, Lee J, Chapman JD. Radiat Res; 1986 Feb; 105(2):169-79. PubMed ID: 3952269 [Abstract] [Full Text] [Related]
11. [Concept of therapeutic ratio by combination of radiotherapy and chemotherapy]. Tanaka Y. Gan No Rinsho; 1983 Oct; 29(13):1579-83. PubMed ID: 6668667 [Abstract] [Full Text] [Related]
12. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation. Schreiber A, Krause M, Zips D, Dörfler A, Richter K, Vettermann S, Petersen C, Beuthien-Baumann B, Thümmler D, Baumann M. Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873 [Abstract] [Full Text] [Related]
13. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole. Siemann DW, Morrissey S, Wolf K. Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075 [Abstract] [Full Text] [Related]
14. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Sun JR, Brown JM. Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067 [Abstract] [Full Text] [Related]
15. [Radiosensitization research in cancer therapy]. Sugahara T. Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755 [Abstract] [Full Text] [Related]
18. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K. Anticancer Res; 2006 Mar; 26(2A):1261-70. PubMed ID: 16619533 [Abstract] [Full Text] [Related]
19. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids. Sutherland RM, Bareham BJ, Reich KA. Cancer Clin Trials; 1980 Mar; 3(1):73-83. PubMed ID: 7389039 [Abstract] [Full Text] [Related]
20. The effect of misonidazole as a hypoxic radiosensitizer at low dose. Palcic B, Faddegon B, Skarsgard LD. Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]